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Abstract
 
Cell death by necrosis is typically associated with inflammation, in contrast to apoptosis. We
have identified additional distinctions between the two types of death that occur at the level of
dendritic cells (DCs) and which influence the induction of immunity. DCs must undergo
changes termed maturation to act as potent antigen-presenting cells. Here, we investigated
whether exposure to apoptotic or necrotic cells affected DC maturation. We found that imma-
ture DCs efficiently phagocytose a variety of apoptotic and necrotic tumor cells. However,
only exposure to the latter induces maturation. The mature DCs express high levels of the DC-
restricted markers CD83 and lysosome-associated membrane glycoprotein (DC-LAMP) and
the costimulatory molecules CD40 and CD86. Furthermore, they develop into powerful stim-
ulators of both CD4
 
1
 
 and CD8
 
1
 
 T cells. Cross-presentation of antigens to CD8
 
1
 
 T cells oc-
curs after uptake of apoptotic cells. We demonstrate here that optimal cross-presentation of an-
tigens from tumor cells requires two steps: phagocytosis of apoptotic cells by immature DCs,
which provides antigenic peptides for major histocompatibility complex class I and class II pre-
sentation, and a maturation signal that is delivered by exposure to necrotic tumor cells, their
supernatants, or standard maturation stimuli, e.g., monocyte-conditioned medium. Thus, DCs
are able to distinguish two types of tumor cell death, with necrosis providing a control that is
critical for the initiation of immunity.
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Introduction
 
The immune system has to contend with two types of cell
death and their consequences: necrosis and apoptosis (1–3).
Necrotic and apoptotic cells can be phagocytosed by den-
 
dritic cells (DCs),
 
1
 
 potent initiators of immunity (4–6). How-
ever, uptake is restricted to the immature stage of develop-
ment when DCs are well equipped to acquire antigen but
express low levels of the requisite MHC and costimulatory
molecules needed for T cell stimulation (4). Upon receipt
of a maturation signal, DCs downregulate antigen acquisi-
tion, express higher levels of costimulatory and MHC mol-
ecules, and become stably differentiated to activate resting
T cells. Maturation can be triggered by multiple stimuli,
including LPS, contact allergens, bacteria and viruses, cell
 
products (monocyte-conditioned medium [MCM], TNF-
 
a
 
,
IL-1
 
b
 
, PGE
 
2
 
, IFN-
 
a
 
), immunostimulatory unmethylated
CpG oligonucleotides, and poly(I:C) (7–16), and signaling
molecules (CD40L [17, 18]).
We have recently shown that DCs phagocytose apop-
totic cells and cross-present antigen from these sources to
CD8
 
1
 
 T cells. These studies were performed with DCs
that had undergone maturation after exposure to MCM,
and which have proceeded to downregulate their phago-
cytic capacity (5). We subsequently found that immature
DCs were over fivefold more efficient than mature DCs in
phagocytosing apoptotic cells and that they could serve as
 
targets for antigen-specific CD8
 
1
 
 cells (19). However, it re-
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mained unknown whether immature DCs could stimulate
a resting CD8
 
1
 
 T cell population after acquisition of apop-
totic cells. Since it is the immature DC located in the periph-
ery that captures antigen most efficiently and which most
likely needs a signal to leave the tissue and migrate to the
regional lymph nodes, we investigated whether the uptake
of dead or dying cells could initiate immunity by inducing
DC maturation. Here, we found that exposure to necrotic
but not apoptotic tumor cells provided the requisite matu-
ration signal to DCs that resulted in the upregulation of
maturation-specific markers, costimulatory molecules, and
the capacity to induce antigen-specific CD4
 
1
 
 and CD8
 
1
 
 T
cells. Thus, DCs are able to distinguish two types of tumor
cell death, with necrosis providing a critical signal that will
promote the initiation of immunity. Our data suggest new
approaches to manipulate the immune system so that de-
sired immune responses, e.g., to tumors, can be induced.
 
Materials and Methods
 
DC Culture.
 
DCs were prepared as described previously (20–
22). In brief, DCs were generated from T cell–depleted PBMCs by
culturing cells for 5–6 d in the presence of 1,000 U/ml GM-CSF
(Immunex) and 1,000 U/ml IL-4 (R&D Systems). RPMI 1640
supplemented with 20 
 
m
 
g/ml gentamicin, 10 mM Hepes (GIBCO
BRL), and 1% autologous plasma (heparinized) was used for cell
culture. Cultures were supplemented with cytokines on days 2 and
4. On day 5 or 6, nonadherent immature DCs were collected and
transferred to new 6-well plates. In some cases, DCs were left in
the 6-well plates. Mature DCs were generated by the addition of
50% vol/vol MCM (20) on the day of transfer and harvested on
days 7–8.
 
Induction of Apoptosis and Necrosis.
 
UV-triggered apoptosis was
induced using a 60-mJ UVB lamp (Derma Control, Inc.), cali-
brated to provide 2 mJ/cm
 
2
 
/s. After 8 h, 
 
.
 
50% of the cells were
apoptotic. For the induction of secondary necrosis, the cells were
cultured for 24 h after which 
 
.
 
80% of the cells incorporated try-
pan blue. Primary necrosis was achieved via repeated freezing (at
 
2
 
80
 
8
 
C) and thawing (at
 
 
 
37
 
8
 
C) or by hypotonic lysis. One cycle
of freezing and thawing resulted in mostly intact cells, which in-
corporated trypan blue. In contrast, four to five freeze–thaw cy-
cles resulted in complete disruption of the cells into fragments.
Supernatants were prepared from apoptotic or necrotic cells
(0.5–5 
 
3
 
 10
 
5
 
/ml), by spinning the cells or cell lysates at 1,500
rpm for 10 min. The supernatants were filtered through 0.22-
 
m
 
m
Millipore filters and either used immediately or frozen at 
 
2
 
80
 
8
 
C
until further use.
 
Primary Cells, Cell Lines, and Media.
 
Human cell lines con-
sisting of EBV-transformed B lymphocyte cell lines (B-LCL),
melanoma cells (SK29), and kidney adenocarcinoma
 
 
 
cells (293)
were cultured in RPMI supplemented with 10% FCS. All cell lines
were tested for 
 
Mycoplasma
 
 (
 
Mycoplasma 
 
detection kit; American
Type Culture Collection). Mouse cell lines consisted of melanoma
cells (B16), fibroblasts (L cells), macrophage cell line (RAW), fi-
broblasts (NIH-3T3), and a thymoma line (EL-4) grown in
DMEM supplemented with 10% FCS. Human primary cells con-
sisted of keratinocytes, monocytes, 
 
g
 
-globulin–activated mono-
cytes, influenza-infected monocytes, T cells, mitogen-activated T
blasts, and B cells. Mouse primary cells consisted of liver cells and
kidney cells.
 
Phagocytosis Assay.
 
293 cells were dyed red with PKH26 ac-
 
cording to the manufacturer’s protocol (Sigma Chemical Co.). Im-
mature DCs were dyed green with PKH67 and then cocultured
with the apoptotic and necrotic cells at cell equivalent ratios of 1:1
for 3 h at 4
 
8
 
C or 37
 
8
 
C. Phagocytosis of apoptotic and necrotic cells
by immature DCs was defined by the percentage of double positive
cells by FACS
 
®
 
 analysis as described previously (23).
 
Phagocytosis of Latex Beads.
 
Immature DCs were cocultured
with 5 
 
3
 
 10
 
6
 
 green fluorescent microspheres (diameter 2.16 
 
m
 
m,
2.5% solids, carboxylate-modified latex; Sigma Chemical Co.) with
or without addition of MCM for 48 h (24). They were then col-
lected, separated from unengulfed beads by a buoyant density
separation with Ficoll-Paque (Amersham Pharmacia Biotech), and
stained for CD83 expression.
 
mAbs.
 
mAbs to the following antigens were used. CD83 (un-
conjugated CD83 or CD83-FITC; Immunotech) and DC–lyso-
somal-associated membrane glycoprotein (DC-LAMP; provided
by Dr. S. Lebecque, Schering Plough, Dardilly, France) are mark-
ers expressed primarily by mature DCs. CD86, HLA-DR, CD40,
CD25, CD8, and CD14 were obtained from Becton Dickinson.
Isotype control mAbs included IgG1, IgG2a, and IgG2b (Immu-
notech). The secondary antibody was PE-conjugated F(ab
 
9
 
)
 
2
 
 goat
anti–mouse IgG heavy and light chain (Jackson ImmunoRe-
search Labs). The DC populations were phenotyped with the
panel of mAbs listed above and analyzed on a FACScan™ (Bec-
ton Dickinson). For intracellular staining, cells were first fixed in
1% paraformaldehyde and then permeabilized with 0.5% saponin
before incubation with the primary antibody.
 
T Cell Proliferation Assays.
 
Apoptotic or necrotic cell lines or
their supernatants were added at various ratios to day 5 or 6 imma-
ture DCs. After 48 h of coculture, the DCs were assayed for their
T cell stimulatory capacity. For the superantigen-dependent assay,
DCs were irradiated with 3,000 rad before addition to syngeneic T
cells in the presence of 0.1 ng/ml staphylococcal enterotoxin A
(SEA). After 3 d, 4 
 
m
 
Ci/ml [
 
3
 
H]thymidine was added for 16 h.
 
 
 
We
observed background proliferation in 5-d cocultures of immature
DCs and allogeneic T cells in the MLR, probably because of some
DC maturation as a result of DC–T cell interactions. To avoid this,
we fixed immature DCs after exposure to dying cells with 1%
paraformaldehyde for 30 min on ice, washed extensively, and
added them in graded doses to allogeneic T cells. After 4 d, 4 
 
m
 
Ci/
ml [
 
3
 
H]thymidine was added for 16 h. Immature and MCM-
matured DCs not exposed to dying cells served as controls.
 
ELISA.
 
The measurement of cytokines in the supernatants
of cocultures of DCs and apoptotic cells via ELISA (Endogen)
was performed according to the manufacturer’s protocol. 5 
 
3
 
 10
 
5
 
DCs were cocultured with 2.5 
 
3
 
 10
 
5
 
 B-LCL cells for 18 h with
or without addition of 1 ng/ml LPS, after which the supernatants
were assayed for the release of TNF-
 
a
 
.
 
ELISPOT Assay for IFN-
 
g 
 
Release from Single Antigen-specific
CD8
 
1
 
 T Cells.
 
Enzyme-linked immunospot (ELISPOT) assays
for IFN-
 
g
 
 release from single antigen-specific CD8
 
1
 
 T cells were
performed as described elsewhere (25). 96-well plates (Multiscreen;
Millipore) were coated overnight at 4
 
8
 
C with 10 
 
m
 
g/ml of the
primary anti–IFN-
 
g
 
 mAb (Mabtech), washed, and blocked with
RPMI containing 5% PHS for 1 h at 37
 
8
 
C. Cells were added to
wells for 18 h at 37
 
8
 
C, after which the wells were washed before
a 2-h incubation with 50 
 
m
 
l of the secondary antibody (1 
 
m
 
g/ml,
biotin-conjugated anti–IFN-
 
g
 
 mAb; Mabtech). Avidin-bound
biotinylated horseradish peroxidase H was added (Vectastain Elite
kit; Vector Laboratories) for 1 h at room temperature. The plates
were then washed and incubated for 5 min in stable diaminoben-
zene (Research Genetics) for visualization of the complex. The
spots were counted with a stereomicroscope (Stemi 2000; Carl 
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Zeiss, Inc.). Responses were considered positive if 
 
.
 
10 spot-form-
ing cells (SFCs) were analyzed per 2 
 
3 
 
10
 
5
 
 cells plated and the re-
sponse was at least twofold greater than the respective controls.
 
Assay for Antigen-specific CTLs.
 
Immature DCs were exposed
to supernatants from apoptotic or necrotic EL-4 cell lines or
MCM (33% vol/vol) for 48 h, after which they were pulsed
with 1 
 
m
 
g/ml of the HLA-A
 
*
 
0201–restricted influenza matrix
peptide (GILGFVFTL) for 1 h. DCs were cultured with autologous
HLA-A
 
*
 
0201
 
1
 
 T cells at varying ratios for 7 d. CTL activity was
assayed using a conventional Cr-release assay. The targets were
T2 cells pulsed or unpulsed with 1 
 
m
 
g/ml of the matrix peptide
for 1 h. The E/T ratio was 20:1. Specific lysis was determined by
subtracting the percent killing of unpulsed T2 cells.
 
Results
 
Both Apoptotic and Necrotic Cells Are Phagocytosed by the
DCs.
 
To generate immature DCs, we cultured freshly iso-
lated blood monocytes in GM-CSF and IL-4 for 6 d. These
cells are characterized by low levels of HLA and costimula-
tory molecules (CD40, CD86) (4) and the DC-restricted,
maturation-associated markers CD83 (20–22) and DC-LAMP
(26). We first verified that immature DCs phagocytosed
 
necrotic cells comparably to apoptotic cells (19). A FACS
 
®
 
assay was used where green PKH67GL-labeled DCs are
visually assessed for their ability to take up red PKH26GL-
labeled apoptotic or necrotic tumor cells (kidney adenocar-
cinoma, 293 cells) at a ratio of 1:1 (23). Over 40% of imma-
ture DCs phagocytosed either apoptotic or necrotic cells
within 3 h (Fig. 1, A–C). Phagocytosis of necrotic and apop-
totic cells by DCs was also confirmed visually via immu-
nofluorescence (data not shown). Uptake was profoundly
reduced when dead cells were cocultured with DCs at 4
 
8
 
C,
indicating that cells or cell fragments were not bound non-
specifically. As expected, mature DCs displayed poor phago-
cytic activity for either apoptotic or necrotic cells (Fig. 1
C). As a control for the effects of phagocytosis, we added
FITC-labeled latex beads to immature DCs, which were
then cultured for 48 h in the presence or absence of MCM,
the latter to induce maturation. Uptake of latex beads by it-
self did not induce maturation, as monitored by surface
CD83 expression, and furthermore did not inhibit matura-
tion via MCM (Fig. 1, D and E).
 
DCs Exposed to Necrotic Cells Acquire a Mature Phenotype.
 
We next monitored the effects of dying cells on the matu-
Figure 1. DCs phagocytose apoptotic cells and
necrotic cells. 293 cells were labeled red with the
PKH26GL fluorescent cell linker and induced to
undergo apoptosis via UVB irradiation, or necrosis
via repeated freezing and thawing. Immature DCs
were dyed green with PKH67GL and then cocul-
tured with the apoptotic and necrotic cells for 3 h at
48C or 378C at a ratio of 1:1. Cells were analyzed
by FACScan™ where double positive cells indicate
uptake of the apoptotic and necrotic cells by the
DCs. Dot plots are gated on the FL1 high posi-
tive cells (DCs), thus excluding the dead 293 cells
from the analysis. (A) Green-dyed DCs and red-
dyed apoptotic (293 UV) and necrotic (293 FT)
cells alone. (B) Uptake of apoptotic and necrotic
cells by immature DCs. (C) Uptake of apoptotic
and necrotic cells by mature DCs. The results
shown are representative of 10 different experi-
ments. (D and E) On day 6 of culture, 7 3 105 imma-
ture DCs were cultured with 5 3 106 green fluores-
cent microspheres in the absence (D) or presence
(E) of MCM. On day 8, the DCs were separated
from unengulfed beads by density gradient centrifu-
gation and analyzed by FACScan™ for uptake of la-
tex beads and CD83 expression. 
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ration of DCs. A panel of human cell lines was tested, in-
cluding a melanoma cell line (SK29), kidney adenocarcinoma
cells (293), and EBV-transformed B lymphocyte cell lines
(B-LCL) (Fig. 2 A). Again, a 48-h coculture was carried
out at different ratios of dying cells to DCs (1:5–1:2 for the
cell lines, 1:5–10:1 for primary cells), after which the DCs
were collected, stained for markers indicative of matura-
tion, and analyzed on a FACScan™. Exposure to necrotic
cells, but not apoptotic cells, induced the expression of the
maturation-associated markers CD83 and DC-LAMP in a
large percentage of DCs (Fig. 2, A–C) and upregulated
both costimulatory (CD86) and HLA molecules (Fig. 2, D
and E). Furthermore, CD40 levels almost doubled after ex-
posure to necrotic cells (Fig. 2, D and E). The induction of
maturation was equivalent to that seen with MCM or
poly(I:C) (data not shown) and was irreversible, as DCs did
not revert to an immature phenotype in culture. Necrotic
but not apoptotic mouse cell lines, including L cells, EL-4
cells, NIH-3T3 cells, and B16 melanoma cells, also in-
duced the maturation of DCs. However, primary cells,
e.g., T cells, B cells, monocytes, and keratinocytes, were
ineffective in this regard (data not shown). The same was
true for influenza-infected monocytes induced to undergo
apoptosis or necrosis after infection, as even at a 10:1 ratio
of dead cells to DCs they failed to induce maturation (Fig.
2 F). T cells activated by mitogen stimulation or monocytes
stimulated by 
 
g
 
-globulin also did not induce maturation
(data not shown).
 
Supernatants from Necrotic Cells Induce the Maturation of DCs.
 
To define the nature of factors in necrotic cells that were
responsible for inducing maturation, we collected super-
natants from necrotic and apoptotic cell lines, filtered
them through a 0.22-
 
m
 
m filter, and added these to imma-
ture DC cultures. Supernatants from necrotic but not apop-
totic cells induced maturation (Fig. 2 G). In contrast, su-
pernatants from necrotic primary cells again had no effect
on DC maturation (Fig. 2 H). It was shown recently that
an excess of apoptotic cells can induce maturation of a mu-
rine DC line (27). In that study, apoptotic cells were cul-
tured for up to16 h, before their addition to immature DC
cell lines. Interestingly, when we added apoptotic cells to
DCs at similar ratios of 5:1 or 10:1, there was extensive DC
death (data not shown). It is possible that the phagocytic
capacity of our human DCs was overwhelmed and that the
DCs died as a consequence. Because apoptotic cells can un-
dergo secondary necrosis in long-term cultures, the studies
of Rovere et al. (27) could be explained by the release of
soluble factors that induce maturation. To test this, we
compared the supernatants derived from UV-irradiated tu-
mor cells (e.g., EL-4 cells) cultured for 8 h (when 
 
.
 
50% of
the cells are Annexin V positive) and 24 h (when 
 
.
 
90% of
cells undergo secondary necrosis as visualized by trypan
blue inclusion). Supernatants from apoptotic cells cultured
for 24 h failed to mature DCs (Fig. 2 I). The same was true
for apoptotic cells that were lysed after 8 h (to fragment ap-
optotic cell bodies) or supernatant of live cells cultured for
48 h (data not shown). In addition, we were interested
whether there were differences in supernatants of tumor
cells undergoing limited or extensive necrosis. After one
round of freeze–thaw, the cells are grossly intact but incor-
porate trypan blue, whereas four freeze–thaw cycles result
in complete cellular fragmentation. Interestingly, only su-
Figure 2 (continues on facing page). 
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pernatants of cells that underwent four cycles of freeze–
thaw were effective in maturing DCs, as determined by CD83
expression (Fig. 2 I). To define the active factor contained
within the supernatants of necrotic cells, we examined the
supernatants for inflammatory cytokines. Obvious candi-
dates for maturation, such as TNF-
 
a
 
 and IL-1
 
b
 
, were not
detectable by ELISA (data not shown).
 
DCs Exposed to Necrotic Cells or Their Supernatants Acquire
Potent T Cell Stimulatory Capacity.
 
Mature DCs are potent
stimulators of T cells, the most straightforward assays being
the induction of allogeneic T cell proliferation in the MLR
and superantigen-dependent T cell proliferation (28, 29).
After a 48-h exposure to dying cells or their respective su-
 
pernatants, DCs were washed and added in graded doses to
2 
 
3
 
 10
 
5
 
 allogeneic or syngeneic T cells, in the latter case to-
gether with 0.1 ng/ml SEA. Strong stimulation of allogeneic
and superantigen-stimulated syngeneic T cells was observed
with DCs that had been matured with necrotic cells, their
respective supernatants, or with MCM (Fig. 3, A and B). In
contrast, exposure to apoptotic cells did not induce MLR
stimulatory activity or superantigen-dependent syngeneic
proliferation above the low background in the absence of
MCM (Fig. 3, A and B). The [
 
3
 
H]thymidine uptake data
were confirmed by analysis of T cell size on the FACScan™.
In response to mature DCs (matured with MCM or with
exposure to necrotic cells), 
 
.
 
30% of the CD3
 
1
 
 T cells in the
Figure 2. DCs exhibit a ma-
ture phenotype after exposure to
necrotic but not apoptotic cell
lines.  (A) Apoptotic or necrotic
B-LCL cells were cocultured with
DCs at ratios of 1:2 or 1:5. After
48 h, the DCs were stained extra-
cellularly for CD83 and intracellu-
larly for CD83 and DC-LAMP.
(B and C) DCs were cocultured
with apoptotic or necrotic cell
lines at a ratio of 1:2 for 48 h and
then stained extracellularly for
CD83 and intracellularly for DC-
LAMP. (D) Immature and mature
DCs were stained with mAbs to
CD86, CD40, HLA-DR, and/or
CD83.  Apoptotic (Apop) or ne-
crotic (F/T) cell lines (E), influ-
enza-infected or uninfected mac-
rophages (MO) (F), or supernatants
from dead cells (G) were added to
immature DCs. After 48 h, the
DC were stained with mAbs to
CD83, CD86, CD40, and HLA-
DR. (H) Apoptotic and necrotic
primary cells were cocultured for
48 h with DCs, after which the
CD83 expression of the DCs was
compared with DCs matured with
MCM, LPS, or necrotic (F/T, or
by hypotonic lysis) 293 cells. (I)
Supernatants of apoptotic cells cul-
tured for 8 and for 24 h or super-
natants of partly ablated (13 F/T)
or completely ablated (43 F/T)
cells were added to immature
DCs, and after 48 h the DCs were
stained with an mAb to CD83. In
D, E, and G, values represent the
averages of the geometric mean
indices from three or more experi-
ments. Error bars mark the SD. In
I, a directly labeled anti-CD83
(CD83-PE) antibody was used,
accounting for the lower mean
fluorescence intensities. Isotype-
matched antibodies served as con-
trols in all experiments (data not
shown). In F, H, and I, a represen-
tative experiment of two to four is
shown.428 Necrotic Tumor Cells Induce Dentritic Cell Maturation
MLR were blasts (high forward light scattering), whereas
immature DCs (no MCM, or exposure to apoptotic cells)
induced ,5% blast transformation (not shown).
Importantly, when DCs were exposed to a mixture of
apoptotic and necrotic cells, they induced similar increases
in T cell stimulation as DCs cultured with necrotic cells or
their supernatants (data not shown). Furthermore, DCs ex-
posed in parallel to apoptotic cells and MCM heightened T
cell responses to the same extent as DCs matured with
MCM. These experiments indicated that ingestion of apop-
totic cells did not inhibit DC maturation or function. Ex-
periments where DCs were stimulated with LPS after up-
take of apoptotic cells revealed an uninhibited secretion of
inflammatory cytokines, i.e., TNF-a (Fig. 3 C) or IL-1b,
compared with control DCs that were not cocultured with
apoptotic cells. This contrasts with recently published data
showing that phagocytosis of apoptotic cells induces immu-
nosuppressive and antiinflammatory effects in macrophages
(e.g., release of IL-10 and PGE2 after LPS stimulation) and
that apoptotic cells themselves can be sources of factors
(e.g., IL-10) that skew the immune response (30–32).
Exposure to Necrotic Cell Lines or Their Supernatants Allows
for the Induction of Antigen-specific CD81 Effector Cells. We
next tested the effect of exposing immature DCs to necrotic
or apoptotic cell lines and their respective supernatants on
the induction of antigen-specific CD81 effector cells. DCs
from HLA-A*02011 individuals were exposed to dying tu-
mor cells, their supernatants, or MCM for 2 d. The cells were
then collected, pulsed with the HLA-A*0201–restricted in-
fluenza matrix peptide (GILGFVFTL), and cocultured with
syngeneic T cells for 7 d. The induction of influenza-spe-
cific IFN-g–producing CD81 cells was tested after restim-
ulating the T cells with matrix peptide–pulsed autologous
DCs in an ELISPOT assay, whereas the cytolytic activity of
responding T cells was tested directly on matrix peptide–
pulsed T2 target cells in a conventional chromium-release
assay. Only DCs exposed to necrotic cell lines, their superna-
tants, or MCM permitted the induction of matrix peptide–
specific CD81 effector cells (Fig. 4, A and B), whereas ex-
posure to apoptotic cell lines or their supernatants was not
effective.
A Maturation Signal Provided by Necrotic Cell Lines, Their
Respective Supernatants, or MCM Is Required for Optimal
Cross-Presentation of Antigens Derived from Apoptotic Cells.
In previous studies, we found that mature DCs can present
antigens from apoptotic cells or tumor lines to elicit CD81
CTL responses (5). However, phagocytosis of apoptotic cells
is maximal when DCs are immature (19). As exposure of
immature DCs to apoptotic cell lines fails to mature them,
we tested whether the addition of necrotic cell lines, their
supernatants, or MCM would enhance antigen cross-presen-
tation. Immature DC cultures (derived from HLA-A*02011
monocytes) were fed with influenza-infected or uninfected
apoptotic EL-4 cells and supplemented with either super-
natants of apoptotic or necrotic cell lines or MCM. After
48 h, the DCs were collected and cocultured with 2 3 105
syngeneic T cells at a ratio of 1:15. 18 h later, antigen-spe-
cific (IFN-g) production by CD81 T cells was measured in
Figure 3. DCs gain heightened T
cell stimulatory capacity after expo-
sure to necrotic but not apoptotic cell
lines. Apoptotic or necrotic cell lines
(B-LCL) were added at a ratio of 1:5 to
day 5 or 6 immature DCs. After 48 h
of coculture, the DCs were assayed
for their T cell stimulatory capacity.
(A) DCs were irradiated with 3,000
rad using a cesium irradiator before
addition to 2 3 105 syngeneic T cells
and 0.1 ng/ml SEA. After 3 d, 4 mCi/
ml [3H]thymidine was added for 16 h.
(B) After coculture with apoptotic or
necrotic cell lines (B-LCL) or their re-
spective supernatants (sup), DCs were
fixed with 1% paraformaldehyde for
30 min at 48C, washed extensively,
and added in graded doses to 2 3 105
allogeneic T cells. After 4 d, 4 mCi/
ml [3H]thymidine was added for 16 h.
Immature and MCM-matured DCs
served as controls. T cells cultured
alone gave counts ,600 cpm. Results
are representative of three or more
experiments, and the values shown
represent the mean of triplicate wells.
(C) 5 3 105 DCs were cocultured
with apoptotic B-LCL cells (Apop-
LCL) at a 2:1 ratio with or without the
addition of 1 ng/ml LPS. After 16 h,
the supernatants were tested for
TNF-a release by ELISA.429 Sauter et al.
an ELISPOT assay. We have previously shown that the pri-
mary cells making IFN-g in this assay are CD81 T cells (25).
Only DCs matured via exposure to necrotic cell supernatants
or MCM were able to induce influenza-specific CD81 ef-
fector cells after the phagocytosis of influenza-infected EL-4
cells (Fig. 5). It was necessary to use supernatant from cell
lines that had undergone four freeze–thaw cycles, consis-
tent with our observation that extensive necrosis is required
to release maturation factors (Fig. 2 I). Neither early nor late
apoptotic cell supernatants allowed for the induction of sig-
nificant levels of IFN-g–producing SFCs. Fig. 5 (right) shows
that once mature, DCs efficiently present the HLA-A*02011
restricted influenza matrix peptide to syngeneic T cells.
The number of SFCs obtained with matrix peptide–pulsed,
MCM-matured DCs was similar to that measured when
DCs were fed apoptotic influenza-infected EL-4 cells and
matured with 43 necrotic cell supernatant. We conclude
that immature DCs phagocytose apoptotic cells (19) but do
not efficiently cross-present antigens from these cells unless
they receive a maturation stimulus. Fig. 5 is notable in pro-
viding the first demonstration of cross-presentation by DCs
to CD81 T cells where xenogeneic cells are the source of
antigen.
Discussion
While a role for macrophages in the phagocytic clear-
ance of both apoptotic and necrotic cells is well established,
less is known about how dying cells are dealt with by DCs.
Macrophages phagocytose apoptotic cells via several recep-
tors, thereby allowing for their efficient clearance (1). Con-
comitantly, macrophages are primed to produce immuno-
regulatory factors such as IL-10, TGF-b, and PGE2 while
the production of proinflammatory cytokines (e.g., IL-12,
TNF-a) is suppressed (30–32). Moreover, macrophages
degrade rather than process antigens contained within apop-
totic cells, as they fail to induce antigen-specific CTLs
when injected in vivo (33) and are not recognized as targets
of CTLs in vitro (19). Altogether, these data suggest that
macrophages modulate the immune response after phago-
cytosis of apoptotic cells by the release of immunosuppres-
sive factors and failure to present antigen. Exposure of mac-
rophages to necrotic cells leads to macrophage activation,
Figure 4. Immature DCs matured via necrotic supernatants are able to induce antigen-specific CD81 effector cells. Cocultures of immature DCs were
supplemented with nothing, MCM, or supernatants (sup) of apoptotic (UVB-irradiated B-LCL) or necrotic (frozen–thawed B-LCL) cells and incubated
for 48 h. They were collected, unpulsed or pulsed with 1 mg/ml influenza matrix peptide for 1 h, and cocultured with 2 3 105 syngeneic T cells at a ratio
of 1:30 for 7 d to allow for the activation of CD81 effector cells. Responding T cells were collected and restimulated with autologous DCs that were un-
treated or pulsed with matrix peptide (MP) for 18 h. The induction of influenza matrix peptide–specific CD81 T cells was measured in an IFN-g
ELISPOT assay (A). Alternatively, 7-d cocultures were directly tested for matrix peptide–specific CTL activity in a 4-h chromium-release assay using
matrix peptide–pulsed T2 cells as targets (B). Results are representative of three experiments, and the values shown represent the mean of triplicate wells.
Figure 5. Exposure of immature DCs to maturation stimuli is necessary
for optimal cross-presentation of antigen derived from apoptotic cells.
EL-4 cells were infected or uninfected with influenza virus and induced
to undergo apoptosis by UVB irradiation. Apoptotic cells were fed to im-
mature DCs at a ratio of 1:20 and simultaneously exposed to MCM or su-
pernatants (sup) from EL-4 cell lines. Supernatants were derived from
UVB-irradiated EL-4 lines that were cultured for 8 vs. 24 h, or lines that
had undergone one (13) vs. four (43) freeze–thaw cycles. After 48 h, the
DCs were collected and cocultured with syngeneic T cells. Cross-presen-
tation of influenza antigen was detected by monitoring IFN-g–producing
SFCs in an ELISPOT assay. The data shown were calculated after sub-
tracting the background values, i.e., the number of SFCs obtained when
apoptotic uninfected ELA cells were fed to immature DCs. These values
ranged from 0 to 30/106 T cells. Additional controls consisted of imma-
ture and MCM-matured DCs, which were pulsed with 1 mg/ml of the
influenza matrix peptide (MP) before coculture with syngeneic T cells.430 Necrotic Tumor Cells Induce Dentritic Cell Maturation
indicating the importance of distinguishing the effects of cell
death upon APCs (34).
In contrast to macrophages, we find striking differences
in the handling of dying tumor lines or transformed cell
lines by DCs depending on the mechanism of cell death.
Although DCs efficiently phagocytose both necrotic and
apoptotic cells, only exposure to necrotic tumor cells or
transformed cell lines, or their soluble derivatives, selectively
induces the maturation of DCs. As this paper was under re-
view, a similar phenomenon was described with murine
DCs (34a). DCs also seem to distinguish between these two
forms of death at the level of antigen presentation. We
have previously shown that uptake of apoptotic cells by
DCs is required for cross-presentation of antigens to CD81
T cells (5), whereas both apoptotic and necrotic cells can
serve as sources of antigen for the activation of CD41 T
cells (6). Our studies now add another refinement to these
pathways. Optimal cross-presentation of antigens acquired
from dying cells by DCs requires two steps: first, the effi-
cient acquisition of dying cells via phagocytosis when DCs
are in their immature state where uptake is severalfold
more efficient than in the mature state (19); and second,
the receipt of a maturation signal that can be provided by
necrotic cell fragments, their soluble supernatants, or stan-
dard maturation stimuli, e.g., MCM. As a result, the anti-
gen presentation can be improved almost 5–10-fold. Im-
mature DCs can process antigens derived from apoptotic
cells as they are lysed by CTL lines in short-term assays (19).
However, to activate CD81 T cells, either IFN-g effector
cells or CTLs, the DCs must undergo maturation, a state
characterized by the upregulation of MHC and costimula-
tory molecules and the production of cytokines such as IL-
12. In previous studies, we used mature DC populations to
phagocytose apoptotic cells and cross-present viral and tu-
mor antigens to both CD41 and CD81 T cells (5, 6).
These mature populations are not likely to be synchronous,
explaining why a small percentage can still phagocytose ap-
optotic material (5) and permit cross-presentation of anti-
genic material onto MHC class I and II molecules. Another
distinction between DCs and macrophages in their han-
dling of apoptotic cells is that DCs are not inhibited in their
ability to produce proinflammatory cytokines, whereas mac-
rophages become primed to produce immunosuppressive cy-
tokines and factors (30, 31). This has been demonstrated in
vivo, where DCs but not macrophages pulsed with apop-
totic tumor cells induced an antitumor response (33).
Our studies uncovered an important distinction between
the sources of necrotic cells required to induce DC matura-
tion. We found that only certain types of cells, namely tumor
lines, were capable of inducing DC maturation after necrosis.
These included transformed cells of both human (SK29 mela-
noma cells, 293 cells, B-LCL cells, and HeLa cells) and mu-
rine origin (EL-4 cells, L cells, RAW cells, and NIH-3T3
cells). When we tested primary cells (keratinocytes, T cells,
monocytes, and B cells) and cells derived from whole tissues
(mouse liver and kidney), we were unable to detect matura-
tion-inducing factor, even if they were added at an excess.
Activation of T cells with mitogen or of monocytes with
g-globulin also failed to elicit this activity. This apparent dis-
tinction between primary cells and lines remains unexplained
but may be due to the paucity of such factors in primary cells,
and/or their induction in tumor lines possibly related or sec-
ondary to a transformation or cell cycle event. It also became
clear from our studies that a certain extent of necrosis was re-
quired to release the maturation factors from tumor lines, i.e.,
four cycles of freeze–thaw versus one cycle. The former led
to complete fragmentation of cells and presumably organelles
and nuclei, whereas in the latter, dead but grossly intact cells
were still evident. The distinction between primary and sec-
ondary necrosis also became apparent when we compared su-
pernatants derived from necrotic versus 24-h-old apoptotic
cells. The former but not the latter contained maturation fac-
tors. These data are consistent with the concept that apoptotic
cells are noninflammatory, even when they are relatively
“old,” at least as it pertains to DCs. Therefore, only in the
setting of some inflammatory (e.g., cell lysis secondary to viral
infection or release of cytotoxic cytokines) or stressful event
(e.g., trauma or toxicity), where complete cell fragmentation
is induced, may maturation factors be released.
The nature of the activating molecules provided by ne-
crotic cells to DCs is the subject of ongoing investigation.
The “danger model” proposed by Matzinger suggests that
dendritic cells are activated by endogenous alarm signals re-
leased by stressed, damaged, or necrotic peripheral tissue
cells (35). Two likely candidates known to be involved in
DC maturation, namely TNF-a and IL-1b, were not de-
tectable in our supernatants. As murine lines also served as
sources of maturation factors, cytokines seem less likely to
be involved here. Janeway (36) has proposed that DCs ex-
press nonclonal pattern recognition receptors (PRRs) that
recognize invariant molecular structures in pathogens (patho-
gen-associated molecular patterns [PAMPs]). PAMPs ex-
pressed or induced by LPS, viruses, and bacteria may in-
duce DC maturation (36). As some of our tumor lines were
virally transformed, we cannot exclude the possibility that
factors expressing PAMPs are involved. Double-stranded
RNA (produced by RNA viruses like influenza), recently
demonstrated to be a potent inducer of DC maturation (15,
16), may be another such candidate. Other studies have
shown that tumor cell death by nonapoptotic mechanisms,
e.g., necrosis, is characterized by the induction of high lev-
els of mRNA for heat shock proteins that may target anti-
gens to immature DCs (37, 38). Interestingly, heat shock
proteins have been implicated in cross-priming pathways
(39). It remains to be seen whether these molecules are se-
lectively released in different types of tumor cell death and
whether they can affect DC maturation.
Curiously, when we cocultured an excess of influenza-
infected monocytes with immature DCs, this did not lead
to their maturation. Macrophages infected with influenza
produce GM-CSF, IL-1, and TNF-a, but only low levels
of virus and undergo rapid spontaneous apoptosis (40). It is
possible that insufficient levels of cytokines, virus, or dou-
ble-stranded RNA are produced in vitro to induce DC
maturation. The failure of infected monocytes, whether
apoptotic or necrotic, to mature DCs might be circum-431 Sauter et al.
vented in vivo by inflammatory cytokines from surround-
ing infected tissues. In addition, opsonizing the apoptotic
cell might provide an alternative signal to target the apop-
totic cells to DCs and induce their maturation (41). Since
some viruses may not access professional APCs, mechanisms
must exist in vivo whereby virus-specific responses are in-
duced. A recent study indicated that bone marrow–derived
cells are needed in vivo to cross-present antigens from vi-
rus-infected peripheral tissues (42); however, the mecha-
nism remains undetermined.
We envision different scenarios depending on which type
of dying cell DCs may encounter in vivo. We would pre-
dict that uptake of necrotic tumor cells would lead to the
initiation of T cell responses to antigens processed by the
DCs. These responses are likely to be CD41 rather than
CD81, as antigens derived from necrotic cells do not seem
to induce CTLs, at least in vitro (5). Phagocytosis of apop-
totic cells by DCs failed to induce maturation, the conse-
quences of which may be the induction of tolerance to self
or tumor antigens (43–45). However, phagocytosis of apop-
totic cells may lead to T cell immunity if followed by a
maturation signal. Signals provided by necrotic cells in the
environment, cytokines (e.g., TNF-a, IL-1, or IFN-a re-
leased by virus-infected cells), inflammatory products (e.g.,
LPS or bacterial cell walls), and CD41 T cells (such as
CD40L–CD40 interactions) (17, 18, 46–48) would be re-
quired to condition the DC, thus allowing for the full acti-
vation of T cells. In fact, in in vivo animal models of cross-
priming and cross-tolerance, induction and maintenance of
CTLs require CD41 help (49, 50).
In conclusion, our study reveals novel biological differ-
ences between apoptotic and necrotic tumor cells. For the
most part, effective immunity is not induced to antigens in
tumors, which might be expected to undergo some level of
cell turnover through apoptosis, and secondary necrosis.
Since successful immunotherapy in many cases seems to be
reduced to the problem of creating the right inflammatory
reaction (e.g., GM-CSF–transduced tumor lines or BCG
injections [51, 52]), necrosis might be one of the elements
critical for the induction of tumor immunity. In fact, mu-
rine studies have suggested that the immunogenicity of tu-
mors is influenced by the mechanism of cell death in vivo.
In situ killing of tumor cells by nonapoptotic mechanisms is
associated with high immunogenicity, whereas apoptotic cell
death is considerably less immunogenic (37). Our data sug-
gest that by inducing necrosis where only apoptosis is prev-
alent, the immune system could be redirected to generate a
favorable response.
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